
Sign up to save your podcasts
Or


2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients.
By Biotechnology Innovation Organization4.9
8383 ratings
2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocates for sickle cell patients.

21,967 Listeners

32,091 Listeners

30,692 Listeners

961 Listeners

761 Listeners

6,381 Listeners

501 Listeners

394 Listeners

4,153 Listeners

6,427 Listeners

259 Listeners

2,314 Listeners

420 Listeners

228 Listeners

1,670 Listeners